Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1752 of 5804
-
Digital doubles of patient airways could speed up bronchoscopy training
Knowledge-focused Recruiting nowThis study aims to determine whether multi-patient CT-derived digital twin anatomical variability training can shorten the early clinical learning curve of novice bronchoscopists compared with conventional anatomically uniform bronchoscopy simulation training.
Phase: NA • Sponsor: Gang Hou • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
New PET tracer targets cancer cells for sharper tumor imaging
Diagnosis Recruiting nowThis Phase I/II clinical study, titled "A Study to Evaluate the Safety and Diagnostic Performance of F18 FBPA PET/CT Imaging in Solid Tumors", aims to evaluate the safety and diagnostic performance of F18 FBPA PET/CT imaging in subjects with solid tumors. The primary objective is…
Phase: PHASE1, PHASE2 • Sponsor: Heron Neutron Medical Corp. • Aim: Diagnosis
Last updated Jul 11, 2026 00:00 UTC
-
New formula aims to help long COVID sufferers walk farther
Disease control Recruiting nowThis will be a six-week, randomized, parallel, two group, open-label design. Patients will be treated with Paragon Novel Metabolic Regulator (PNMR) + standard of care (SOC) or SOC alone for 6 weeks for the treatment of Long COVID. All patients will also be provided with with Diet…
Phase: PHASE2 • Sponsor: ParagonClinicals Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New hope for kidney disease: JADE101 trial launches
Disease control Recruiting nowThis open-label Phase 2 study will characterize the safety and efficacy of JADE101 in participants with IgA nephropathy, and the results will contribute to the overall clinical characterization of JADE101 in this patient population.
Phase: PHASE2 • Sponsor: Jade Biosciences, Inc. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New combo therapy for CLL tested in Real-World settings
Disease control Recruiting nowThe purpose of this study is to see how well Ibrutinib and Venetoclax (I+V) treatment works (effectiveness) for participants with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) when it is used in routine, everyday medical care.
Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New injection aims to tame tough eczema
Disease control Recruiting nowThe purpose of this Phase 1 study is to evaluate the safety and tolerability of a new investigational drug called SSGJ-716 in healthy adults and in participants with moderate-to-severe atopic dermatitis (AD). The study has two parts. The first part (Single Ascending Dose, SAD) w…
Phase: PHASE1 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Tiny pacemaker, big promise: could a leadless device simplify heart pacing?
Disease control Recruiting nowThe study aims to evaluate the following: 1) the incidence of new onset atrial fibrillation in patients with an atrial leadless pacemaker, 2) the need for upgrade from a standalone atrial leadless pacemaker to a dual chamber leadless pacemaker system, and 3) to compare the batter…
Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Poop pills or tubes: could fecal transplants tame deadly transplant complication?
Disease control Not yet recruitingThis is a pilot, prospective, non-profit, multicenter, uncontrolled, open-label study to evaluate the safety and feasibility of FMT in patients aged between 3 months and 25 years suffering from acute intestinal GVHD resistant to conventional steroid therapy. Eligible patients wi…
Phase: PHASE1, PHASE2 • Sponsor: Bambino Gesù Hospital and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for PCOS: drug combo may improve IVF outcomes
Disease control OngoingThe goal of this clinical trial is to evaluate and compare the effectiveness of combined Myoinositol and Metformin therapy versus a combination of Pioglitazone and Metformin, and Metformin alone in infertile women with Polycystic Ovary Syndrome (PCOS) undergoing Intracytoplasmic …
Phase: NA • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a 12-Day cooking class beat malnutrition? bangladesh trial aims to find out
Disease control Not yet recruitingThe goal of this clinical trial (cluster randomized controlled trial) is to learn whether a Positive Deviance/Hearth (PDH) intervention can effectively treat moderate acute malnutrition (MAM) and reduce relapse compared to standard care in children aged 6-59 months diagnosed with…
Phase: NA • Sponsor: World Vision US • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Robotic liver surgery from afar: a new frontier in surgical care?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if the robotic surgical system producted by Shenzhen Edge Medical Company has a non-inferior textbook outcome in liver surgery in the field of remote surgery compared to local robotic surgery. It will also learn about the safety of remo…
Phase: NA • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Ultrasound reveals how jaw pain treatments change muscles
Symptom relief OngoingMyofascial pain is one of the most important symptoms in patients with temporomandibular disorders (TMD). Although the etiological factors leading to TMD have not been definitively established, parafunctional habits such as bruxism and clenching, as well as conditions such as str…
Phase: NA • Sponsor: Istanbul Medipol University Hospital • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New whipworm drug could beat standard treatment in one dose
Disease control Not yet recruitingThe purpose of this clinical trial is to compare the efficacy and safety of emodepside with the standard treatment, albendazole, in adolescents (12 years and older) and adults infected with Trichuris incognita.
Phase: PHASE2 • Sponsor: Jennifer Keiser • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Ambulance blood test could save thousands from unnecessary hospital trips
Diagnosis Not yet recruitingPeople who call emergency medical services (EMS) with chest pain or other possible heart-related symptoms are often taken to hospital for further testing. However, only a small proportion of these patients are ultimately diagnosed with a serious heart condition such as a heart at…
Sponsor: Central Denmark Region • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
New pill could help LADA patients keep making insulin longer
Disease control Not yet recruitingThis single-center, randomized, open-label, controlled study aims to evaluate the effect of cofrogliptin on pancreatic β-cell function in adults with latent autoimmune diabetes in adults (LADA). Following a screening period of up to 6 weeks, 84 eligible participants will be rando…
Phase: NA • Sponsor: Second Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New brain scanner could reveal hidden effects of childhood neurological diseases
Knowledge-focused OngoingOver the past 20 years, doctors have gotten much better at spotting and treating brain conditions caused by the immune system attacking the body. These include illnesses like autoimmune encephalitis, ADEM, and multiple sclerosis. But even with better treatments, many patients-esp…
Phase: NA • Sponsor: Aston University • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Natural supplement astaxanthin tested as new asthma aid in dirty air
Disease control Recruiting nowThis study will test whether astaxanthin, a naturally occurring antioxidant supplement, can improve lung function, reduce airway inflammation, and improve asthma control in adults with mild-to-moderate asthma. Participants will receive astaxanthin and placebo in random order in a…
Phase: NA • Sponsor: Middlesex University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Coaching program aims to combat loneliness and prevent suicide in seniors
Symptom relief Not yet recruitingThe purpose of this study is to test whether an individual coaching program helps adults age 60 and older feel more connected to other people in ways that matter to them.
Phase: NA • Sponsor: University of Rochester • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Ultrasound-Guided nerve block may ease a hidden cause of chronic back pain
Symptom relief Recruiting nowSuperior cluneal nerve entrapment (SCNE) is an underrecognized cause of chronic low back pain and gluteal pain that may mimic lumbar spine disorders. Ultrasound-guided proximal superior cluneal nerve block has increasingly been used in routine clinical practice .Diagnostic superi…
Sponsor: Gaziosmanpasa Research and Education Hospital • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
New experimental drug SIM0613 enters first human tests for advanced cancers
Disease control Recruiting nowThis is a multicenter, open-label, first-in-human (FIH) study to evaluate the safety, tolerability, efficacy and pharmacokinetic/pharmacodynamic characteristics of SIM0613 in participants with locally advanced/ metastatic solid tumors. The study starts with a dose escalation part…
Phase: PHASE1 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC